Neuralink Corp
The CONVOY Study is a clinical trial designed to explore the feasibility of participants from the PRIME Study (NCT06429735) using the N1 Implant to control various assistive devices. The main goal is to determine whether participants can successfully modulate their brain activity to control devices, such as an Assistive Robotic Arm (ARA). This study will assess the effectiveness, consistency, and safety of neural control using the ARA and other assistive devices.
Inclusion Criteria: * Continued enrollment in the PRIME Study. * Implanted with the N1 Implant. Exclusion Criteria: * Explantation or deactivation of the N1 Implant. * Insufficient N1 Implant BCI performance demonstrated. * Lack of a suitable physical space to perform research sessions. * Any condition which, in the opinion of the Investigator, would compromise the candidate's ability to safely participate in the study.
The intervention involves using the N1 Implant, a wireless brain-computer interface (BCI), to enable participants to control the Assistive Robotic Arm through neural signals.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.